Cioffi Melina
SVP, Regulatory Affairs
Cioffi Melina has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: May 18, 2026.
On the most recent filing, Cioffi Melina is listed as SVP, Regulatory Affairs at Aquestive Therapeutics, Inc. Inside the rolling window, Cioffi Melina reported no open-market purchases and 1 open-market sale totaling $106K in AQST.
Companies traded
Other insiders at AQST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$106K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cioffi Melina made?
Cioffi Melina has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Cioffi Melina trade?
Cioffi Melina has filed SEC Form 4 disclosures for 1 company, including AQST.
When was Cioffi Melina's most recent SEC Form 4 filing?
Cioffi Melina's most recent SEC Form 4 filing on Tracefour is dated May 18, 2026.
What is Cioffi Melina's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cioffi Melina is listed as SVP, Regulatory Affairs.
What is Cioffi Melina's total buy and sell value in the current window?
Inside the rolling retention window, Cioffi Melina bought $0 and sold $106K based on SEC Form 4 filings.
What was Cioffi Melina's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,311 AQST shares on 2026-03-10, worth $106K, per SEC Form 4 filings.